Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer
Open Access
- 1 August 1997
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (4) , 537-540
- https://doi.org/10.1038/bjc.1997.421
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prognostic value of the S-phase fraction of breast cancerBritish Journal of Cancer, 1993
- High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.1993
- Consensus review of the clinical utility of dna cytometry in carcinoma of the breastCytometry, 1993
- Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspiratesEuropean Journal Of Cancer, 1993
- Cathepsin D in breast cancer: A tissue marker associated with metastasisEuropean Journal Of Cancer, 1992
- Prognostic value of total cathepsin D in breast tumorsBreast Cancer Research and Treatment, 1991
- Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporationBritish Journal of Cancer, 1991
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- [Drill biopsy and puncture biopsy for the determination of hormone receptors].1983
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957